Nurse Search Results

Experts will address the variability of practice with IV push medication use, including
unnecessary unit-based preparation and dilution and unsafe injection practices, highlighting
strategies necessary for the mitigation of risk.

This activity will address the multi-factorial risks associated with IV medications,
along with the need for proven safety technologies, practice innovation, and educational
strategies to enhance safety in all phases of the medication use process.

Multiple sclerosis (MS) affects an estimated 400,000 people in the U.S., with approximately
10,000 new cases reported every year. As a chronic and progressive neurologic disease
that requires lifelong, dynamic treatment via costly, high-touch medications that
also require special handling and storage, multiple sclerosis therapies are often
delivered via specialty pharmacy programs. This activity provides an introduction
to MS pathology, epidemiology, and symptom management to specialty pharmacists and
nurses.

Multiple sclerosis (MS) affects an estimated 400,000 people in the U.S., with approximately
10,000 new cases reported every year. As a chronic and progressive neurologic disease
that requires lifelong, dynamic treatment via costly, high-touch medications that
also require special handling and storage, multiple sclerosis therapies are often
delivered via specialty pharmacy programs. This activity provides an in-depth discussion
of the various therapies used in the treatment of MS.

Multiple sclerosis (MS) affects an estimated 400,000 people in the U.S., with approximately
10,000 new cases reported every year. As a chronic and progressive neurologic disease
that requires lifelong, dynamic treatment via costly, high-touch medications that
also require special handling and storage, multiple sclerosis therapies are often
delivered via specialty pharmacy programs. This activity discusses the transitions
of care, patient adherence strategies and financial considerations in the management
of MS.

Multiple sclerosis (MS) affects an estimated 400,000 people in the U.S., with approximately
10,000 new cases reported every year. As a chronic and progressive neurologic disease
that requires lifelong, dynamic treatment via costly, high-touch medications that
also require special handling and storage, multiple sclerosis therapies are often
delivered via specialty pharmacy programs. This capstone activity of the MS curriculum
uses case studies to allow participants to apply what was learned in modules MS-101
through MS-103.

ISMP’s presentation will address the multi-factorial risks associated with intravenous medications and the need for adoption of proven technologies and best practices to optimize the safety and reliability of sterile compounding.

This activity will provide pharmacists and nurses with an improved knowledge of PAH,
including a review of pathophysiology, disease subcategories, diagnosis, treatment
guidelines, approved therapies, disease progression, and disease monitoring recommendations.

This webinar will describe the latest changes in procedural and practice expectations
and will educate participants about Institute for Safe Medication Practices (ISMP)
guidelines for adult IV push medications, which were developed as a result of a national
summit.